Latest Articles

Publication Date
A framework linking polygenic risk to precision gynecological disease models - Bioengineer.org

A framework linking polygenic risk to precision gynecological disease models Bioengineer.org

Published: Sept. 8, 2026, 1:37 a.m.
Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis.

Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies …

Published: Sept. 8, 2026, midnight
Gynecological Devices Market to Reach USD 24.4 Billion by 2036 Amid Rising Women's Healthcare Demand - industrytoday.co.uk

Gynecological Devices Market to Reach USD 24.4 Billion by 2036 Amid Rising Women's Healthcare Demand industrytoday.co.uk

Published: Sept. 7, 2026, 9:30 p.m.
Elevated Neutrophil Count as a Causal Risk Factor for Endometriosis: A Mendelian Randomization Study.

Endometriosis is a chronic inflammatory gynecological disorder where immune dysregulation plays a central role in its pathogenesis. While previous observational studies have reported associations between circulating blood cell counts and …

Published: Sept. 5, 2026, midnight
Exosomal miR-22-3p targets p53 to regulate endometrial epithelial cell function in the pathogenesis of endometriosis.

Endometriosis (EMs) is a widespread gynecological disease, affecting approximately 6-10% of females of child-bearing age. Despite its significant influence on women's health, the specific pathophysiology remains unclear. The enrichment of …

Published: Sept. 4, 2026, midnight
Gynecological Devices Market to Grow from USD 11.29 Billion - GlobeNewswire

Gynecological Devices Market to Grow from USD 11.29 Billion GlobeNewswire

Published: Sept. 2, 2026, 11:38 a.m.
Gynecological Devices Market to Grow from USD 11.29 Billion - globenewswire.com

Gynecological Devices Market to Grow from USD 11.29 Billion globenewswire.com

Published: Sept. 2, 2026, 11:38 a.m.
Vaginal Sclerotherapy for Endometrioma: A Retrospective Study on Feasibility and Impact on Fertility.

To evaluate the feasibility and effectiveness of vaginal ethanol sclerotherapy (EST) for ovarian endometriomas, with a focus on recurrence and subsequent fertility outcomes.

Published: Sept. 2, 2026, midnight
Standardized Reporting in Gynecological Ultrasonography in India: The Need of the Hour.

Gynecological ultrasonography (USG) is integral to evaluating adnexal masses, adenomyosis, endometriosis, and other pelvic pathologies. Despite advances in imaging, substantial variability in terminology and reporting persists, potentially leading to inconsistent …

Published: Aug. 31, 2026, midnight
Exploring Short-Acting Hormonal Contraceptives in Endometriosis Care-A Narrative Review and Evidence-Based Practical Considerations.

Endometriosis is a chronic, estrogen-dependent inflammatory condition affecting approximately 10% of women of reproductive age and manifesting with pelvic pain, dysmenorrhea, dyspareunia, fatigue, and infertility. First-line treatment in most patients …

Published: Aug. 30, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!